Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6-Reference-Cited by-同舟云学术

Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6

Published:2007-02 Issue:2 Volume:25 Page:401-411
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Hoepken Hans-Hermann,Gispert Suzana,Morales Blas,Wingerter Oliver,Del Turco Domenico,Mülsch Alexander,Nussbaum Robert L.,Müller Klaus,Dröse Stefan,Brandt Ulrich,Deller Thomas,Wirth Brunhilde,Kudin Alexei P.,Kunz Wolfram S.,Auburger Georg

Publisher

Elsevier BV

Subject

Neurology

Reference68 articles.

1. Parkinson’s disease-redox mechanisms;Adams;Curr. Med. Chem.,2001

2. A generalised increase in protein carbonyls in the brain in Parkinson’s but not incidental Lewy body disease;Alam;J. Neurochem.,1997

3. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra;Alam;J. Neurochem.,1997

4. Severe impairment of complex I-driven adenosine triphosphate synthesis in leber hereditary optic neuropathy cybrids;Baracca;Arch. Neurol.,2005

5. Chronic systemic pesticide exposure reproduces features of Parkinson’s disease;Betarbet;Nat. Neurosci.,2000

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. β-asarone relieves Parkinson’s disease through reducing intracellular Ca2+ in PINK1 mutant Drosophila melanogaster;2023-05-08

2. CtBP Neuroprotective Role in Toxin-Based Parkinson’s Disease Models: From Expression Pattern to Dopaminergic Survival;Molecular Neurobiology;2023-04-15

3. Outlook of PINK1/Parkin signaling in molecular etiology of Parkinson’s disease, with insights into <i>Pink1</i> knockout models;Zoological Research;2023

4. Mitophagy in the aging nervous system;Frontiers in Cell and Developmental Biology;2022-10-11

5. Induced Pluripotent Stem Cells for the Treatment of Neurodegenerative Disease: Current and Future Prospects;Regenerative Therapies in Ischemic Stroke Recovery;2022